Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006279.5(ST3GAL3):āc.118A>Gā(p.Asn40Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
ST3GAL3 (HGNC:10866): (ST3 beta-galactoside alpha-2,3-sialyltransferase 3) The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Mar 19, 2019
The c.118A>G variant (also known as p.N40D), located in coding exon 1 of the ST3GAL3 gene, results from an A to G substitution at nucleotide position 118. The amino acid change results in asparagine to aspartic acid at codon 40, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);Loss of ubiquitination at K40 (P = 0.0107);